Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics.

MLA

Li, Songye, et al. “Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 60, no. 7, July 2019, pp. 1023–30. EBSCOhost, https://doi.org/10.2967/jnumed.118.220517.

APA

Li, S., Zheng, M.-Q., Naganawa, M., Kim, S., Gao, H., Kapinos, M., Labaree, D., & Huang, Y. (2019). Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 60(7), 1023–1030. https://doi.org/10.2967/jnumed.118.220517

Chicago

Li, Songye, Ming-Qiang Zheng, Mika Naganawa, Sujin Kim, Hong Gao, Michael Kapinos, David Labaree, and Yiyun Huang. 2019. “Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 60 (7): 1023–30. doi:10.2967/jnumed.118.220517.